How to diagnose 'persistent infection' that leads to gastritis, gastric ulcers, and gastric cancer —Helicobacter pylori ...

Der Katzenurin-Entferner Bio Urin Attacke von Dipure wird gebrauchsfertig geliefert und besteht nur aus natürlichen ...

Urease is one of the most consequential enzymes in the microbial world. By hydrolyzing urea into ammonia and carbon dioxide, ...

Pancreatic cancer is one of the deadliest forms of cancer—because it is so hard to detect, cases are typically caught in the late stages of the disease. A person can live with pancreatic cancer for ...

On August 24, 2026, the U.S. FDA cleared a new single-biomarker blood test to help doctors detect signs of Alzheimer’s disease. The test helps doctors determine both rule-in (positive result) and rule ...

The Food and Drug Administration (FDA) has granted approval for a new test for Alzheimer’s disease, marking the fourth time such a blood test has been approved in less than two years. Roche announced ...

The US Food and Drug Administration has cleared Roche and partner Eli Lilly’s blood test to help identify signs of Alzheimer’s disease in people age ‌55 and older with cognitive decline. The test, ...

The FDA cleared the Elecsys Phospho-Tau (217P) Plasma blood test, which Roche and Lilly say is the single-biomarker blood test designed to test for the likelihood of amyloid pathology, a brain symptom ...

The test, Elecsys pTau217, is a biomarker blood test that can help doctors identify patients who are likely or unlikely to have Alzheimer's-related brain changes, Roche said on Monday. Sign up here.

Washington — A blood test may predict if apparently healthy older adults are likely to develop Alzheimer's symptoms in the next five or 10 years, researchers reported Wednesday. That information could ...

Blood tests on the horizon, and under federal regulatory view, may be about to transform cancer care — and survival. The Food and Drug Administration has been evaluating a blood test called Galleri ...

In early studies, the blood test, developed by UCLA scientists, shows promise in detecting multiple cancers. The new method, called MethylScan, works by analyzing cell-free DNA, tiny fragments of ...